###begin article-title 0
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF
###end article-title 0
###begin p 1
###xml 992 999 992 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 490 496 <span type="species:ncbi:10090">murine</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 914 919 <span type="species:ncbi:10090">mouse</span>
###xml 1005 1010 <span type="species:ncbi:10090">mouse</span>
microRNA-155 (miR-155) has been implicated as a central regulator of the immune system, but its function during acute inflammatory responses is still poorly understood. Here we show that exposure of cultured macrophages and mice to lipopolysaccharide (LPS) leads to up-regulation of miR-155 and that the transcription factor c/ebp Beta is a direct target of miR-155. Interestingly, expression profiling of LPS-stimulated macrophages combined with overexpression and silencing of miR-155 in murine macrophages and human monocytic cells uncovered marked changes in the expression of granulocyte colony-stimulating factor (G-CSF), a central regulator of granulopoiesis during inflammatory responses. Consistent with these data, we show that silencing of miR-155 in LPS-treated mice by systemically administered LNA-antimiR results in derepression of the c/ebp Beta isoforms and down-regulation of G-CSF expression in mouse splenocytes. Finally, we report for the first time on miR-155 silencing in vivo in a mouse inflammation model, which underscores the potential of miR-155 antagonists in the development of novel therapeutics for treatment of chronic inflammatory diseases.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 800 801 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 802 803 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8 B9 B10">8&#8211;10</xref>
###xml 989 991 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
MicroRNAs (miRNAs) are an abundant class of small endogenous noncoding RNAs that post-transcriptionally regulate gene expression by base-pairing to imperfect complementary target sites in the 3' UTR of their target mRNAs, thereby mediating mRNA cleavage or translational repression (1). miRNAs have emerged as key regulators of diverse biological processes, including differentiation of hematopoeitic cells (2,3) and activation of the innate immune response (4,5). miR-155 is expressed in activated mature B and T lymphocytes (6,7) and in activated monocytes (8,9), while studies using miR-155 knockout mice have directly linked this miRNA to the functions of the immune system (6,7). In addition, miR-155 has been shown to regulate the production of cytokines, chemokines and transcription factors (6,7) and to be induced by endotoxins, such as bacterial lipopolysaccharide (LPS) (8-10). Recently, miR-155 was shown to direct the generation of immunoglobulin class-switched plasma cells (11) and to directly regulate the AID enzyme (activation-induced cytidine deaminase), which is responsible for the generation of functionally diverse antibody repertoires (12,13). Altogether, these observations strongly imply miR-155 as a central regulator of the immune system.
###end p 3
###begin p 4
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 720 727 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 812 820 812 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 825 832 825 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1437 1439 1437 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1828 1830 1828 1830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 161 167 <span type="species:ncbi:10090">murine</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 677 682 <span type="species:ncbi:10090">mouse</span>
###xml 702 707 <span type="species:ncbi:10090">mouse</span>
With the goal of gaining further insights into the biological function of miR-155 during acute inflammatory response, we have undertaken stimulation of cultured murine macrophage Raw264.7 and human THP-1 monocytic cells as well as treatment of mice by bacterial LPS. Previous studies have shown that the transcription factor CCAAT/enhancer binding protein Beta (c/ebp Beta) is induced in monocytes and macrophages by LPS (14) and that c/ebp Beta is involved in the regulation of proinflammatory cytokines as well as other genes associated with macrophage activation and the acute phase response (15,16). We report here that LPS treatment induces miR-155 expression in cultured mouse macrophages and in mouse splenocytes in vivo and that silencing of miR-155 leads to derepression of its direct target c/ebp Beta in vitro and in vivo. Additionally, we find that antagonism of miR-155 leads to down-regulation of G-CSF, a regulator of granulopoiesis, produced by activated macrophages during acute inflammatory responses. G-CSF belongs to the class of colony-stimulating factors (CSFs), which comprise granulocyte/macrophage CSF (GM-CSF), macrophage CSF (M-CSF) and granulocyte CSF (G-CSF). During progression of inflammatory diseases the CSFs have been suggested to constitute a pro-inflammatory CSF network, which at the site of inflammation involves CSF-mediated communication between stimulated macrophages and neighboring cell types (17). This positive-feedback loop model predicts that CSF blocking agents could be efficient anti-inflammatory drugs. Indeed, data from animal models indicate that depletion of CSFs has therapeutic value in inflammatory and autoimmune diseases. While early-phase clinical trials targeting GM-CSF and M-CSF have been initiated, no clinical trials on depletion of G-CSF have yet been reported (18).
###end p 4
###begin p 5
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Our data show for the first time that c/ebp Beta is regulated by miR-155 in vivo in mouse splenocytes during inflammatory responses. Moreover, we report that miR-155 mediates regulation of G-CSF expression, thereby underscoring the role of miR-155 in fine-tuning important regulatory networks during inflammation.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Design and synthesis of LNA oligonucleotides
###end title 7
###begin p 8
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sup>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sup>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sup>
###xml 467 468 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sup>
###xml 509 510 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sup>
###xml 239 245 <span type="species:ncbi:10090">murine</span>
###xml 342 347 <span type="species:ncbi:9606">human</span>
The LNA-antimiR oligonucleotides were synthesized as unconjugated and fully phosphorothiolated oligonucleotides. The perfectly matching LNA-antimiR oligonucleotide 5'-TcAcAATtaGmCAtTA-3' was complementary to nucleotides 2-16 in the mature murine miR-155 sequence and 5'-TcAcGATtaGmCAtTA-3' was complementary to nucleotides 2-16 in the mature human miR-155 sequence. The mismatch LNA control oligonucleotide was synthesized with the following sequence: 5'-TcAamCATtaGAmCtTA-3' (uppercase: LNA; lowercase: DNA; mC denotes LNA methylcytosine).
###end p 8
###begin title 9
Cell culture
###end title 9
###begin p 10
###xml 1373 1380 1357 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 722 727 <span type="species:ncbi:9606">Human</span>
###xml 1009 1014 <span type="species:ncbi:9606">human</span>
Raw264.7 cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) supplemented with 10% FBS, 4 mM Glutamax I and 25 microg/ml Gentamicin (Invitrogen). Lipopolysaccharide (LPS) was purchased from Sigma and activation of Raw264.7 cells was induced by treating cells with 1, 10 or 100 ng/ml LPS for indicated time periods. THP-1 cells were grown in RPMI-1640 (Invitrogen) supplemented with 10% FBS, 4 mM Glutamax I and 25 microg/ml Gentamicin (Invitrogen). Raw264.7 and THP-1 cells were transfected with the Lipofectamine 2000 transfection reagent according to the manufacturer's protocol (Invitrogen) and the LNA-antimiR oligonucleotides were used at a final concentration of 5 nM unless otherwise stated. Human miR-155 precursor (pre-miR-155, Ambion) was cotransfected at a final concentration of 5 nM. HeLa cells were cultivated in Eagles MEM (Invitrogen) with 10% FBS, 2 mM Glutamax I, non-essential amino acids and 25 microg/ml Gentamicin (Invitrogen). HeLa cells were co-transfected with human pre-miR-155 (Ambion) at a final concentration of 50 nM and 0.1 microg luciferase reporter construct using Lipofectamine 2000. The transfections and luciferase activity measurements were carried out according to the manufacturer's instructions (Invitrogen Lipofectamine 2000/Promega Dual-luciferase kit). Relative luciferase activity levels were expressed as Renilla/firefly luciferase ratios.
###end p 10
###begin title 11
Plasmids
###end title 11
###begin p 12
###xml 113 120 113 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 496 503 496 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1279 1281 1279 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 53 59 <span type="species:ncbi:10090">murine</span>
###xml 221 227 <span type="species:ncbi:10090">murine</span>
###xml 330 335 <span type="species:ncbi:9606">human</span>
###xml 450 455 <span type="species:ncbi:9606">human</span>
###xml 605 610 <span type="species:ncbi:9606">human</span>
###xml 1156 1159 <span type="species:ncbi:10116">rat</span>
The perfect match target sites for the human and the murine miR-155, respectively, were cloned downstream of the Renilla luciferase gene (XhoI/NotI sites) in the psiCHECK2 vector (Promega) using 5' phosphorylated oligos: murine miR-155 forward 5'-tcgagcccctatcacaattagcattaagc-3', and reverse 5'-ggccgcttaatgctaattgtgataggggc-3'; human miR-155 forward 5'-tcgagcccctatcacgattagcattaagc-3' and reverse 5'-ggccgcttaatgctaatcgtgatagggg-3'. The 3' UTR of human c/ebp Beta was cloned downstream of the Renilla luciferase gene (XhoI/NotI sites) in the psiCHECK2 vector. PCR primers used for amplification of the human c/ebp Beta 3' UTR (basepairs 1328-1837 accession no. NM_005194) were: forward 5'-aaaaaactcgagaaaactttggcactggggca-3' (incl. a XhoI site), reverse 5'-aaaaaagcggccgcggctttgtaaccattctcaaa-3' (incl. a NotI site). The miR-155 target site in the c/ebp Beta 3' UTR was mutated by deleting the 8 nt miR-155 seed match sequence (AGCAUUAA at nucleotide positions 554-561 in the c/ebp Beta 3' UTR) using the QuikChange Site-Directed Mutagenesis kit according to manufacturer's instructions (Stratagene). The pCDNA3.1 expression construct for the truncated rat c/ebp Beta isoform LIP (amino acids 153-297) was kindly provided by Dr. M.A. Chidgey and has been described elsewhere (19).
###end p 12
###begin title 13
Western blot analysis
###end title 13
###begin p 14
###xml 555 560 <span type="species:ncbi:10090">mouse</span>
###xml 633 639 <span type="species:ncbi:9986">rabbit</span>
###xml 696 701 <span type="species:ncbi:10090">mouse</span>
###xml 779 785 <span type="species:ncbi:9986">rabbit</span>
###xml 791 796 <span type="species:ncbi:10090">mouse</span>
###xml 814 819 <span type="species:ncbi:9823">swine</span>
###xml 825 831 <span type="species:ncbi:9986">rabbit</span>
Raw264.7 and spleen proteins were extracted using RIPA lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate) and electrophoresed on NuPAGE Bis Tris 4-12% gels (Invitrogen) using 100 microg protein per sample. The proteins were transferred to a nitrocellulose membrane using iBlot (Invitrogen) according to manufacturer's instructions. ECL advanced western kit (GE Healthcare Life Sciences) was used for blocking, antibody dilution and detection according to the manufacturer. A primary monoclonal mouse-anti-c/ebp Beta antibody (SC-7962, Santa Cruz Biotechnology), a primary rabbit-anti-PU.1 (#2258, Cell signaling Technology), a primary mouse-anti- Tubulin-alpha Ab-2 (MS-581-P, Neomarkers) and HRP-conjugated secondary rabbit anti-mouse (P0447, DAKO) or swine anti-rabbit antibodies (P0399, DAKO) were used according to the manufacturer's instructions.
###end p 14
###begin title 15
Quantitative RT-PCR
###end title 15
###begin p 16
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 559 564 <span type="species:ncbi:10090">mouse</span>
###xml 1466 1471 <span type="species:ncbi:10090">mouse</span>
The dissected mice spleens were immediately stored in RNA later (Ambion). Total RNA from spleens or Raw264.7 cells was extracted with Trizol reagent according to the manufacturer's instructions (Invitrogen), except that the precipitated RNA pellet was washed in 80% ethanol and not mixed. The miR-155 levels were quantified using the mirVana real-time RT-PCR detection kit (Ambion) following the manufacturer's instructions, except that 200 ng total RNA was used in the reverse transcription (RT) reaction. A 2-fold total RNA dilution series from LPS-treated mouse spleen RNA or LPS-treated Raw264.7 RNA served as standard to ensure a linear range (Ct versus relative copy number) of the amplification. The RT reaction was diluted ten times in water and 10 microl aliquots were subsequently used for RT-PCR amplification according to the manufacturer's instructions (Ambion). mRNA quantification of selected genes was done using standard TaqMan assays (Applied Biosystems). The reverse transcription reaction was carried out with random decamers, 0.5 mug total RNA and the M-MLV RT enzyme from Ambion according to protocol. First-strand cDNA was subsequently diluted 10 times in nuclease-free water before addition to the RT-PCR reaction mixture. The Applied Biosystems 7500 Real-Time PCR instrument was used for amplification, except that the Applied Biosystems 7900 Real-Time PCR instrument was used for amplification of 96 transcripts included on the low density mouse immune array from Applied Biosystems.
###end p 16
###begin title 17
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo experiments
###end title 17
###begin p 18
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
C57BL/6J female mice (Taconic Europe A/S) kept on a regular chow diet (Altromin no 1324, Brogaarden) and with an average body weight of approximately20 g (+/-2 g) at the start of the experiment were used in all studies. The experiments were carried out following the Danish Committee for Animal Experiments guidelines. The animal cages were illuminated to give a 12-h light/dark cycle. The temperature was 21degreesC +/- 2degreesC and relative humidity 55 +/- 10%. The LNA compounds were formulated in physiological saline (0.9% NaCl) to a final concentration allowing the mice to receive a tail vein injection volume of 10 ml/kg. The animals were dosed for three consecutive days with LNA-antimiR, LNA control or saline (vehicle control), receiving daily doses of 25 mg/kg and sacrificed 24 h after last dose. Saline-formulated bacterial LPS was administered by intraperitoneal injections at 0.5 mg/kg and the mice were sacrificed either 2 or 24 h post-LPS treatment. Immediately after sacrificing the animals, spleen samples were dissected.
###end p 18
###begin title 19
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Isolation of B cells and monocytic/macrophage cell fractions from mice splenocytes
###end title 19
###begin p 20
###xml 16 20 <span type="species:ncbi:10090">mice</span>
C57BL/6J female mice (Taconic Europe A/S) were injected intravenously with a FAM-labeled LNA control for three consecutive days, receiving daily doses of 25 mg/kg and the animals were sacrificed 24 h after last dose. Spleens were surgically removed and positive selection of monocytes/macrophages was carried out by MACS(R) Cell separation systems (Miltenyi Biotech) using magnetic beads conjugated with CD11b antibodies and the MACS(R) Cell separation columns according to the manufacturer's instructions (Miltenyi Biotec). B cells were isolated using magnetic beads conjugated with CD19 antibodies (Miltenyi Biotec). PE-conjugated CD11b and CD19 antibodies were added to isolated fractions to verify the identity of the isolated cells by FACS analysis. Fixed isolated cells were DAPI stained and transferred to microscope slides. Cellular uptake of the FAM-labeled LNA oligonucleotide was investigated by confocal microscopy.
###end p 20
###begin title 21
RESULTS
###end title 21
###begin title 22
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
LPS-mediated induction of miR-155 in cultured mouse Raw264.7 macrophages
###end title 22
###begin p 23
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8 B9 B10">8&#8211;10</xref>
###xml 401 409 401 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 541 548 541 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 738 746 738 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 971 979 971 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 984 991 984 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1541 1549 1541 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1760 1769 1760 1769 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1844 1845 1844 1845 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2008 2009 2006 2007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2017 2018 2015 2016 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2421 2422 2417 2418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2430 2431 2426 2427 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2746 2747 2740 2741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1769 2753 1769 2747 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="24">LPS-mediated induction of miR-155 in cultured mouse Raw264.7 macrophages. (<bold>A</bold>) Quantitative RT-PCR analysis of miR-155 expression in Raw264.7 cells stimulated with LPS for 18 h at the indicated concentrations. Values represent mean &#177; SD (<italic>n</italic> = 3). (<bold>B</bold>) Assessment of luciferase reporter activity in Raw264.7 cells transfected with either the Renilla/firefly luciferase psiCHECK2 control or psiCHECK2 harbouring the miR-155 perfect match target site in the 3&#8242; UTR of the Renilla luciferase transcript (miR-155 sensor). After transfection, the Raw264.7 cells were stimulated with the indicated concentrations of LPS for 18 h. Values represent mean &#177; SD (<italic>n</italic> = 3). (<bold>C</bold>) Assessment of luciferase reporter activity in Raw264.7 cells cotransfected with LNA-antimiR or LNA control in combination with either the Renilla/firefly luciferase psiCHECK2 control (data not shown) or the miR-155 sensor. Raw264.7 cells were stimulated with 100 ng/ml LPS for 18 h. Values represent mean &#177; SD (<italic>n</italic> = 3).</p>
###xml 1769 2753 1769 2747 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="24">LPS-mediated induction of miR-155 in cultured mouse Raw264.7 macrophages. (<bold>A</bold>) Quantitative RT-PCR analysis of miR-155 expression in Raw264.7 cells stimulated with LPS for 18 h at the indicated concentrations. Values represent mean &#177; SD (<italic>n</italic> = 3). (<bold>B</bold>) Assessment of luciferase reporter activity in Raw264.7 cells transfected with either the Renilla/firefly luciferase psiCHECK2 control or psiCHECK2 harbouring the miR-155 perfect match target site in the 3&#8242; UTR of the Renilla luciferase transcript (miR-155 sensor). After transfection, the Raw264.7 cells were stimulated with the indicated concentrations of LPS for 18 h. Values represent mean &#177; SD (<italic>n</italic> = 3). (<bold>C</bold>) Assessment of luciferase reporter activity in Raw264.7 cells cotransfected with LNA-antimiR or LNA control in combination with either the Renilla/firefly luciferase psiCHECK2 control (data not shown) or the miR-155 sensor. Raw264.7 cells were stimulated with 100 ng/ml LPS for 18 h. Values represent mean &#177; SD (<italic>n</italic> = 3).</p></caption>
###xml 2753 2753 2747 2747 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp577f1"/>
###xml 1760 2753 1760 2747 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="24">LPS-mediated induction of miR-155 in cultured mouse Raw264.7 macrophages. (<bold>A</bold>) Quantitative RT-PCR analysis of miR-155 expression in Raw264.7 cells stimulated with LPS for 18 h at the indicated concentrations. Values represent mean &#177; SD (<italic>n</italic> = 3). (<bold>B</bold>) Assessment of luciferase reporter activity in Raw264.7 cells transfected with either the Renilla/firefly luciferase psiCHECK2 control or psiCHECK2 harbouring the miR-155 perfect match target site in the 3&#8242; UTR of the Renilla luciferase transcript (miR-155 sensor). After transfection, the Raw264.7 cells were stimulated with the indicated concentrations of LPS for 18 h. Values represent mean &#177; SD (<italic>n</italic> = 3). (<bold>C</bold>) Assessment of luciferase reporter activity in Raw264.7 cells cotransfected with LNA-antimiR or LNA control in combination with either the Renilla/firefly luciferase psiCHECK2 control (data not shown) or the miR-155 sensor. Raw264.7 cells were stimulated with 100 ng/ml LPS for 18 h. Values represent mean &#177; SD (<italic>n</italic> = 3).</p></caption><graphic xlink:href="gkp577f1"/></fig>
###xml 145 151 <span type="species:ncbi:10090">murine</span>
###xml 222 227 <span type="species:ncbi:10090">mouse</span>
###xml 710 715 <span type="species:ncbi:10090">mouse</span>
###xml 1338 1343 <span type="species:ncbi:10090">mouse</span>
###xml 1741 1746 <span type="species:ncbi:10090">mouse</span>
###xml 1815 1820 <span type="species:ncbi:10090">mouse</span>
Since miR-155 has previously been shown to be upregulated during macrophage activation (8-10) we first investigated the expression of miR-155 in murine Raw264.7 macrophage cells upon LPS stimulation. Treatment of cultured mouse macrophages with LPS showed dose-dependent induction of miR-155 with more than 10-fold increase in miR-155 expression levels at a concentration of 100 ng/ml LPS after 18 h (Figure 1A). Consistent with these data, a luciferase reporter construct harbouring a perfect match miR-155 target site in the 3' UTR of the Renilla luciferase gene showed a concentration-dependent repression of the luciferase reporter, which correlated with the increased expression of miR-155 in LPS-treated mouse Raw264.7 macrophages (Figure 1B). We have recently reported on effective miRNA silencing using complementary LNA-antimiR oligonucleotides in combination with transcriptome analysis as a useful approach to dissect the biological roles of individual miRNAs in vitro and in vivo (20,21). Hence, to enable further studies on miR-155 targets and miR-155 associated gene networks, we designed an LNA-antimiR complementary to mature miR-155 alongside an LNA control oligonucleotide having four mismatches in the miR-155 recognition sequence. The LNA-antimiR-155 showed concentration-dependent silencing of miR-155 in LPS-treated mouse Raw264.7 macrophages as shown by efficient derepression of the miR-155 sensor, whereas the LNA control oligonucleotide had no effect on the luciferase reporter activity at the same concentrations (Figure 1C). Since the LNA-antimiR resulted in potent and specific antagonism of miR-155 in cultured Raw264.7 cells at 5-nM concentration, we chose these experimental conditions for further studies in mouse macrophages. Figure 1.LPS-mediated induction of miR-155 in cultured mouse Raw264.7 macrophages. (A) Quantitative RT-PCR analysis of miR-155 expression in Raw264.7 cells stimulated with LPS for 18 h at the indicated concentrations. Values represent mean +/- SD (n = 3). (B) Assessment of luciferase reporter activity in Raw264.7 cells transfected with either the Renilla/firefly luciferase psiCHECK2 control or psiCHECK2 harbouring the miR-155 perfect match target site in the 3' UTR of the Renilla luciferase transcript (miR-155 sensor). After transfection, the Raw264.7 cells were stimulated with the indicated concentrations of LPS for 18 h. Values represent mean +/- SD (n = 3). (C) Assessment of luciferase reporter activity in Raw264.7 cells cotransfected with LNA-antimiR or LNA control in combination with either the Renilla/firefly luciferase psiCHECK2 control (data not shown) or the miR-155 sensor. Raw264.7 cells were stimulated with 100 ng/ml LPS for 18 h. Values represent mean +/- SD (n = 3).
###end p 23
###begin p 24
###xml 75 76 75 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 239 240 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 248 249 246 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 652 653 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 661 662 657 658 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 977 978 971 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
LPS-mediated induction of miR-155 in cultured mouse Raw264.7 macrophages. (A) Quantitative RT-PCR analysis of miR-155 expression in Raw264.7 cells stimulated with LPS for 18 h at the indicated concentrations. Values represent mean +/- SD (n = 3). (B) Assessment of luciferase reporter activity in Raw264.7 cells transfected with either the Renilla/firefly luciferase psiCHECK2 control or psiCHECK2 harbouring the miR-155 perfect match target site in the 3' UTR of the Renilla luciferase transcript (miR-155 sensor). After transfection, the Raw264.7 cells were stimulated with the indicated concentrations of LPS for 18 h. Values represent mean +/- SD (n = 3). (C) Assessment of luciferase reporter activity in Raw264.7 cells cotransfected with LNA-antimiR or LNA control in combination with either the Renilla/firefly luciferase psiCHECK2 control (data not shown) or the miR-155 sensor. Raw264.7 cells were stimulated with 100 ng/ml LPS for 18 h. Values represent mean +/- SD (n = 3).
###end p 24
###begin title 25
Translational repression of c/ebp Beta isoforms by miR-155
###end title 25
###begin p 26
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 459 467 459 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 568 569 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 589 590 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 677 685 677 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1051 1059 1051 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1068 1077 1068 1077 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1138 1139 1138 1139 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1488 1489 1488 1489 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1937 1938 1935 1936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2066 2067 2064 2065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2079 2080 2077 2078 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2475 2476 2471 2472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2484 2485 2480 2481 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1077 2826 1077 2822 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="27">Translational repression of c/ebp Beta isoforms by miR-155. (<bold>A</bold>) Schematic overview of the c/ebp Beta transcript. The miR-155 target site is indicated in the 3&#8242; UTR with the 8-nt seed match boxed. TAD, transactivation domain; bZIP, basic region leucine zipper domain; ATG, translational start site; LAP, liver-enriched transcriptional activation protein; LIP, liver-enriched transcriptional inhibitory protein. (<bold>B</bold>) Assessment of luciferase reporter activity in HeLa cells cotransfected with pre-miR-155 in combination with either the Renilla/firefly luciferase psiCHECK2 control, the psiCHECK2 luciferase construct (miR-155 sensor) harbouring the miR-155 perfect match target site, the psiCHECK2 construct harbouring the c/ebp Beta 3&#8242; UTR, or the psiCHECK2 c/ebp Beta 3&#8242; UTR Mut construct harbouring a mutated miR-155 target site. Values represent mean &#177; SD (<italic>n</italic> = 3). The pre-miR-155 significantly represses the luciferase activity of the c/ebp Beta 3&#8242; UTR sensor construct (*** indicates <italic>P</italic> &lt; 0.001). (<bold>C</bold>) Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms and Pu.1 in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Values represent mean &#177; SD (<italic>n</italic> = 3). (<bold>D</bold>) Western blot analysis of the c/ebp Beta LAP and LIP isoforms and Pu.1 protein in THP-1 cell lysates. Protein extracts from THP-1 cells cotransfected with pre-miR-155 (5 nM) in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. Data are representative of three independent experiments.</p>
###xml 1077 2826 1077 2822 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="27">Translational repression of c/ebp Beta isoforms by miR-155. (<bold>A</bold>) Schematic overview of the c/ebp Beta transcript. The miR-155 target site is indicated in the 3&#8242; UTR with the 8-nt seed match boxed. TAD, transactivation domain; bZIP, basic region leucine zipper domain; ATG, translational start site; LAP, liver-enriched transcriptional activation protein; LIP, liver-enriched transcriptional inhibitory protein. (<bold>B</bold>) Assessment of luciferase reporter activity in HeLa cells cotransfected with pre-miR-155 in combination with either the Renilla/firefly luciferase psiCHECK2 control, the psiCHECK2 luciferase construct (miR-155 sensor) harbouring the miR-155 perfect match target site, the psiCHECK2 construct harbouring the c/ebp Beta 3&#8242; UTR, or the psiCHECK2 c/ebp Beta 3&#8242; UTR Mut construct harbouring a mutated miR-155 target site. Values represent mean &#177; SD (<italic>n</italic> = 3). The pre-miR-155 significantly represses the luciferase activity of the c/ebp Beta 3&#8242; UTR sensor construct (*** indicates <italic>P</italic> &lt; 0.001). (<bold>C</bold>) Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms and Pu.1 in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Values represent mean &#177; SD (<italic>n</italic> = 3). (<bold>D</bold>) Western blot analysis of the c/ebp Beta LAP and LIP isoforms and Pu.1 protein in THP-1 cell lysates. Protein extracts from THP-1 cells cotransfected with pre-miR-155 (5 nM) in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. Data are representative of three independent experiments.</p></caption>
###xml 2826 2826 2822 2822 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp577f2"/>
###xml 1068 2826 1068 2822 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="27">Translational repression of c/ebp Beta isoforms by miR-155. (<bold>A</bold>) Schematic overview of the c/ebp Beta transcript. The miR-155 target site is indicated in the 3&#8242; UTR with the 8-nt seed match boxed. TAD, transactivation domain; bZIP, basic region leucine zipper domain; ATG, translational start site; LAP, liver-enriched transcriptional activation protein; LIP, liver-enriched transcriptional inhibitory protein. (<bold>B</bold>) Assessment of luciferase reporter activity in HeLa cells cotransfected with pre-miR-155 in combination with either the Renilla/firefly luciferase psiCHECK2 control, the psiCHECK2 luciferase construct (miR-155 sensor) harbouring the miR-155 perfect match target site, the psiCHECK2 construct harbouring the c/ebp Beta 3&#8242; UTR, or the psiCHECK2 c/ebp Beta 3&#8242; UTR Mut construct harbouring a mutated miR-155 target site. Values represent mean &#177; SD (<italic>n</italic> = 3). The pre-miR-155 significantly represses the luciferase activity of the c/ebp Beta 3&#8242; UTR sensor construct (*** indicates <italic>P</italic> &lt; 0.001). (<bold>C</bold>) Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms and Pu.1 in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Values represent mean &#177; SD (<italic>n</italic> = 3). (<bold>D</bold>) Western blot analysis of the c/ebp Beta LAP and LIP isoforms and Pu.1 protein in THP-1 cell lysates. Protein extracts from THP-1 cells cotransfected with pre-miR-155 (5 nM) in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. Data are representative of three independent experiments.</p></caption><graphic xlink:href="gkp577f2"/></fig>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
LPS stimulation of cultured mouse Raw264.7 cells leads to an inflammatory response in which miR-155 and more than 700 genes are up-regulated (22), including the transcription factor c/ebp Beta gene (14). Interestingly, the c/ebp Beta transcript is predicted by several computer algorithms (PicTar, miRanda, TargetScan) to be a miR-155 target due to the presence of a miR-155 target site in its 3' UTR, which is highly conserved among five vertebrate species (Figure 2A). Indeed, we found that a luciferase reporter harbouring the c/ebp Beta 3' UTR showed significant (P < 0.001, Student's t-test, two-sided) miR-155-dependent repression relative to a control reporter plasmid (Figure 2B), implying that c/ebp Beta is a direct target of miR-155, which is also consistent with two recent reports (23,24). Deletion of the highly conserved miR-155 seed match site (positions 554-561; AGCAUUAA) in the c/ebp Beta 3' UTR abrogated the effect of miR-155. Combined these data support the notion that c/ebp Beta is post-transcriptionally regulated by miR-155 (Figure 2B and ). Figure 2.Translational repression of c/ebp Beta isoforms by miR-155. (A) Schematic overview of the c/ebp Beta transcript. The miR-155 target site is indicated in the 3' UTR with the 8-nt seed match boxed. TAD, transactivation domain; bZIP, basic region leucine zipper domain; ATG, translational start site; LAP, liver-enriched transcriptional activation protein; LIP, liver-enriched transcriptional inhibitory protein. (B) Assessment of luciferase reporter activity in HeLa cells cotransfected with pre-miR-155 in combination with either the Renilla/firefly luciferase psiCHECK2 control, the psiCHECK2 luciferase construct (miR-155 sensor) harbouring the miR-155 perfect match target site, the psiCHECK2 construct harbouring the c/ebp Beta 3' UTR, or the psiCHECK2 c/ebp Beta 3' UTR Mut construct harbouring a mutated miR-155 target site. Values represent mean +/- SD (n = 3). The pre-miR-155 significantly represses the luciferase activity of the c/ebp Beta 3' UTR sensor construct (*** indicates P < 0.001). (C) Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms and Pu.1 in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Values represent mean +/- SD (n = 3). (D) Western blot analysis of the c/ebp Beta LAP and LIP isoforms and Pu.1 protein in THP-1 cell lysates. Protein extracts from THP-1 cells cotransfected with pre-miR-155 (5 nM) in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. Data are representative of three independent experiments.
###end p 26
###begin p 27
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 411 412 411 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 860 861 858 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 989 990 987 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1002 1003 1000 1001 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1398 1399 1394 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1407 1408 1403 1404 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Translational repression of c/ebp Beta isoforms by miR-155. (A) Schematic overview of the c/ebp Beta transcript. The miR-155 target site is indicated in the 3' UTR with the 8-nt seed match boxed. TAD, transactivation domain; bZIP, basic region leucine zipper domain; ATG, translational start site; LAP, liver-enriched transcriptional activation protein; LIP, liver-enriched transcriptional inhibitory protein. (B) Assessment of luciferase reporter activity in HeLa cells cotransfected with pre-miR-155 in combination with either the Renilla/firefly luciferase psiCHECK2 control, the psiCHECK2 luciferase construct (miR-155 sensor) harbouring the miR-155 perfect match target site, the psiCHECK2 construct harbouring the c/ebp Beta 3' UTR, or the psiCHECK2 c/ebp Beta 3' UTR Mut construct harbouring a mutated miR-155 target site. Values represent mean +/- SD (n = 3). The pre-miR-155 significantly represses the luciferase activity of the c/ebp Beta 3' UTR sensor construct (*** indicates P < 0.001). (C) Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms and Pu.1 in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Values represent mean +/- SD (n = 3). (D) Western blot analysis of the c/ebp Beta LAP and LIP isoforms and Pu.1 protein in THP-1 cell lysates. Protein extracts from THP-1 cells cotransfected with pre-miR-155 (5 nM) in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) were subjected to western blot analysis. Data are representative of three independent experiments.
###end p 27
###begin p 28
###xml 144 152 144 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
The c/ebp Beta transcript encodes three isoforms, designated as LAP*, LAP and LIP, that are generated by differential translational initiation (Figure 2A). The short LIP form lacks the transactivation domain (TAD), but is still capable of binding to DNA and forms homo- or heterodimers through the basic region leucine zipper (bZIP) domain and therefore behaves as a dominant negative. The expression of the three isoforms is regulated in a complex manner, and even differential activation of the c/ebp Beta isoforms upon LPS stimulation has been reported (25).
###end p 28
###begin p 29
###xml 618 626 618 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 752 760 752 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1042 1050 1042 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 112 118 <span type="species:ncbi:10090">murine</span>
###xml 327 332 <span type="species:ncbi:10090">mouse</span>
###xml 923 928 <span type="species:ncbi:9606">human</span>
To assess miR-155-mediated regulation of the various c/ebp Beta isoforms, we investigated protein extracts from murine macrophages by Western blot analyses using a C-terminal specific c/ebp Beta antibody that recognizes all three isoforms. Transient transfection of a precursor miR-155 (pre-miR-155) at 5-nM concentration into mouse Raw264.7 macrophages resulted in significant repression of the c/ebp Beta isoforms LIP and LAP, whereas concomitant transfection with equimolar LNA-antimiR into the cells effectively antagonized the miR-155-mediated c/ebp Beta repression compared to the LNA control transfected cells (Figure 2C). We also observed repression of another direct miR-155 target, the Ets family transcription factor Pu.1 in Raw264.7 cells (Figure 2C) (11), implying that both c/ebp Beta and Pu.1 are targeted by miR-155 in the Raw264.7 macrophage model system. We obtained similar results with undifferentiated human monocytic THP-1 cells, in which transfection with pre-miR-155 resulted in repression of the c/ebp Beta isoforms (Figure 2D). Taken together, our data suggest that the levels of individual c/ebp Beta isoforms are regulated by ectopically expressed miR-155.
###end p 29
###begin title 30
miR-155 regulates c/ebp Beta in Raw264.7 cells during LPS stimulation
###end title 30
###begin p 31
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 431 439 431 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 774 783 774 783 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1268 1269 1266 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1289 1290 1287 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1311 1312 1309 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 783 1367 783 1365 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="32">Regulation of c/ebp Beta isoforms by endogenous miR-155 in Raw264.7 cells during LPS stimulation. Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells either mock (control) or LNA-antimiR (5 nM) transfected before treatment with 100 ng/ml LPS for 18 h were subjected to western blot analysis. (Right) Quantification of the LIP, LAP and LAP* protein bands shown on the western blot. Values represent mean &#177; SD (<italic>n</italic> = 3) (** indicates <italic>P</italic> &lt; 0.01; * indicates <italic>P</italic> &lt; 0.05). Data represent three independent experiments.</p>
###xml 783 1367 783 1365 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="32">Regulation of c/ebp Beta isoforms by endogenous miR-155 in Raw264.7 cells during LPS stimulation. Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells either mock (control) or LNA-antimiR (5 nM) transfected before treatment with 100 ng/ml LPS for 18 h were subjected to western blot analysis. (Right) Quantification of the LIP, LAP and LAP* protein bands shown on the western blot. Values represent mean &#177; SD (<italic>n</italic> = 3) (** indicates <italic>P</italic> &lt; 0.01; * indicates <italic>P</italic> &lt; 0.05). Data represent three independent experiments.</p></caption>
###xml 1367 1367 1365 1365 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp577f3"/>
###xml 774 1367 774 1365 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="32">Regulation of c/ebp Beta isoforms by endogenous miR-155 in Raw264.7 cells during LPS stimulation. Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells either mock (control) or LNA-antimiR (5 nM) transfected before treatment with 100 ng/ml LPS for 18 h were subjected to western blot analysis. (Right) Quantification of the LIP, LAP and LAP* protein bands shown on the western blot. Values represent mean &#177; SD (<italic>n</italic> = 3) (** indicates <italic>P</italic> &lt; 0.01; * indicates <italic>P</italic> &lt; 0.05). Data represent three independent experiments.</p></caption><graphic xlink:href="gkp577f3"/></fig>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
###xml 732 737 <span type="species:ncbi:10090">mouse</span>
We next investigated the effect of endogenous miR-155 on c/ebp Beta expression during LPS stimulation by treating mouse macrophage Raw264.7 cells with LNA-antimiR followed by exposure of the cells to LPS. Western blot analysis using the C-terminal specific c/ebp Beta antibody showed that the levels of both the LAP and LIP isoforms of c/ebp Beta were increased after treatment with LPS, in accordance with a previous report (14) (Figure 3). Transfection of the LNA-antimiR (5 nM) into the Raw264.7 macrophages prior to LPS stimulation resulted in derepression of the c/ebp Beta isoforms (Figure 3), which thereby provides additional evidence that the levels of individual c/ebp Beta isoforms are regulated by endogenous miR-155 in mouse macrophages during LPS stimulation. Figure 3.Regulation of c/ebp Beta isoforms by endogenous miR-155 in Raw264.7 cells during LPS stimulation. Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells either mock (control) or LNA-antimiR (5 nM) transfected before treatment with 100 ng/ml LPS for 18 h were subjected to western blot analysis. (Right) Quantification of the LIP, LAP and LAP* protein bands shown on the western blot. Values represent mean +/- SD (n = 3) (** indicates P < 0.01; * indicates P < 0.05). Data represent three independent experiments.
###end p 31
###begin p 32
###xml 485 486 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 506 507 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 528 529 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regulation of c/ebp Beta isoforms by endogenous miR-155 in Raw264.7 cells during LPS stimulation. Western blot analysis of c/ebp Beta LAP*, LAP and LIP isoforms in Raw264.7 cell lysates. Protein extracts from Raw264.7 cells either mock (control) or LNA-antimiR (5 nM) transfected before treatment with 100 ng/ml LPS for 18 h were subjected to western blot analysis. (Right) Quantification of the LIP, LAP and LAP* protein bands shown on the western blot. Values represent mean +/- SD (n = 3) (** indicates P < 0.01; * indicates P < 0.05). Data represent three independent experiments.
###end p 32
###begin title 33
###xml 63 67 <span type="species:ncbi:10090">mice</span>
miR-155 regulates c/ebp Beta in the splenocytes of LPS-treated mice
###end title 33
###begin p 34
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 536 543 536 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 929 937 929 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1145 1153 1145 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1358 1366 1358 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1408 1410 1408 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1585 1593 1585 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1723 1731 1723 1731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1825 1832 1825 1832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1890 1899 1890 1899 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1969 1970 1969 1970 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2281 2282 2281 2282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2585 2586 2583 2584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2732 2733 2730 2731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2745 2746 2743 2744 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2853 2854 2851 2852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2874 2875 2872 2873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2897 2898 2895 2896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 3288 3289 3286 3287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1899 3328 1899 3324 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="35">miR-155 regulates c/ebp Beta in the splenocytes of LPS-treated mice. (<bold>A</bold>) Fluorescence-microscopy analysis of LNA oligonucleotide uptake in mouse splenocytes sorted in either B-cell (CD19) or monocytic (CD11b) cell fractions. Mice were dosed intravenously with 25 mg/kg FAM-labeled LNA oligonucleotide for three consecutive days, and spleens were dissected the day after last dose. (<bold>B</bold>) Quantitative RT-PCR analysis of miR-155 expression in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean &#177; SD (<italic>n</italic> = 5). The LNA-antimiR compound effectively antagonizes miR-155 expression in LPS-treated mice compared to saline treated controls (*** indicates <italic>P</italic> &lt; 0.001). (<bold>C</bold>) Western blot analysis of the c/ebp Beta LAP and LIP isoforms in splenocytes of mice treated with saline (<italic>n</italic> = 3), LNA-antimiR (<italic>n</italic> = 5) or LNA control (<italic>n</italic> = 5) by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 24 h after intraperitoneal injection of 0.5 mg/kg LPS. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Systemically delivered LNA-antimiR compound derepresses the LIP isoform of c/ebp Beta compared to both saline- and LNA control-treated mice (**<italic>P</italic> &lt; 0.01). Values represent mean &#177; SD.</p>
###xml 1899 3328 1899 3324 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="35">miR-155 regulates c/ebp Beta in the splenocytes of LPS-treated mice. (<bold>A</bold>) Fluorescence-microscopy analysis of LNA oligonucleotide uptake in mouse splenocytes sorted in either B-cell (CD19) or monocytic (CD11b) cell fractions. Mice were dosed intravenously with 25 mg/kg FAM-labeled LNA oligonucleotide for three consecutive days, and spleens were dissected the day after last dose. (<bold>B</bold>) Quantitative RT-PCR analysis of miR-155 expression in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean &#177; SD (<italic>n</italic> = 5). The LNA-antimiR compound effectively antagonizes miR-155 expression in LPS-treated mice compared to saline treated controls (*** indicates <italic>P</italic> &lt; 0.001). (<bold>C</bold>) Western blot analysis of the c/ebp Beta LAP and LIP isoforms in splenocytes of mice treated with saline (<italic>n</italic> = 3), LNA-antimiR (<italic>n</italic> = 5) or LNA control (<italic>n</italic> = 5) by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 24 h after intraperitoneal injection of 0.5 mg/kg LPS. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Systemically delivered LNA-antimiR compound derepresses the LIP isoform of c/ebp Beta compared to both saline- and LNA control-treated mice (**<italic>P</italic> &lt; 0.01). Values represent mean &#177; SD.</p></caption>
###xml 3328 3328 3324 3324 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp577f4"/>
###xml 1890 3328 1890 3324 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="35">miR-155 regulates c/ebp Beta in the splenocytes of LPS-treated mice. (<bold>A</bold>) Fluorescence-microscopy analysis of LNA oligonucleotide uptake in mouse splenocytes sorted in either B-cell (CD19) or monocytic (CD11b) cell fractions. Mice were dosed intravenously with 25 mg/kg FAM-labeled LNA oligonucleotide for three consecutive days, and spleens were dissected the day after last dose. (<bold>B</bold>) Quantitative RT-PCR analysis of miR-155 expression in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean &#177; SD (<italic>n</italic> = 5). The LNA-antimiR compound effectively antagonizes miR-155 expression in LPS-treated mice compared to saline treated controls (*** indicates <italic>P</italic> &lt; 0.001). (<bold>C</bold>) Western blot analysis of the c/ebp Beta LAP and LIP isoforms in splenocytes of mice treated with saline (<italic>n</italic> = 3), LNA-antimiR (<italic>n</italic> = 5) or LNA control (<italic>n</italic> = 5) by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 24 h after intraperitoneal injection of 0.5 mg/kg LPS. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Systemically delivered LNA-antimiR compound derepresses the LIP isoform of c/ebp Beta compared to both saline- and LNA control-treated mice (**<italic>P</italic> &lt; 0.01). Values represent mean &#177; SD.</p></caption><graphic xlink:href="gkp577f4"/></fig>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 601 607 <span type="species:ncbi:10090">murine</span>
###xml 730 736 <span type="species:ncbi:10090">murine</span>
###xml 1125 1131 <span type="species:ncbi:10090">murine</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
###xml 1471 1475 <span type="species:ncbi:10090">mice</span>
###xml 1565 1569 <span type="species:ncbi:10090">mice</span>
###xml 1717 1721 <span type="species:ncbi:10090">mice</span>
###xml 1836 1841 <span type="species:ncbi:10090">mouse</span>
###xml 1962 1966 <span type="species:ncbi:10090">mice</span>
###xml 2038 2043 <span type="species:ncbi:10090">mouse</span>
###xml 2124 2128 <span type="species:ncbi:10090">Mice</span>
###xml 2353 2357 <span type="species:ncbi:10090">mice</span>
###xml 2676 2680 <span type="species:ncbi:10090">mice</span>
###xml 2827 2831 <span type="species:ncbi:10090">mice</span>
###xml 3280 3284 <span type="species:ncbi:10090">mice</span>
The expression of c/ebp Beta is induced during macrophage activation, whereas Pu.1 is expressed both in resting B cells and macrophages and in the spleen germinal center B cells (14,26). Since spleen contains populations of monocytes and macrophages together with B and T cells, we investigated miR-155-mediated regulation of c/ebp Beta in the splenocytes of LPS-treated mice in combination with LNA-antimiR based miR-155 silencing. We first asked whether these cells could be targeted by systemically administered LNA oligonucleotides in vivo by isolating B cells and monocytic cell populations from murine spleen after intravenous dosing with a 6-carboxyfluorescein (FAM)-labeled LNA oligonucleotide. Confocal microscopy of the murine B cells and monocytes/macrophages showed that the FAM-labeled LNA was readily taken up by these cells, indicating that miR-155 could be targeted in both cell types by an LNA-antimiR compound (Figure 4A). Intraperitoneal administration of LPS significantly induced the expression of miR-155 in splenocytes 2 h post-treatment, thereby corroborating our results obtained with LPS-stimulated murine macrophages (Figure 4B). The splenocytes of untreated mice showed low levels of c/ebp Beta proteins, whereas the levels of both the LAP and LIP isoform of c/ebp Beta were significantly increased 24 h after treatment with LPS (Figure 4C), in accordance with a previous report (14). Systemic administration of the LNA-antimiR in LPS-treated mice effectively antagonized miR-155 compared to the vehicle and LNA-mismatch-control-treated mice, respectively (Figure 4B). This resulted in significant derepression of both the LAP and LIP isoforms in comparison to the vehicle-treated control mice (Figure 4C), which is consistent with the notion that miR-155 negatively regulates c/ebp Beta proteins in vivo in mouse splenocytes during acute inflammatory response. Figure 4.miR-155 regulates c/ebp Beta in the splenocytes of LPS-treated mice. (A) Fluorescence-microscopy analysis of LNA oligonucleotide uptake in mouse splenocytes sorted in either B-cell (CD19) or monocytic (CD11b) cell fractions. Mice were dosed intravenously with 25 mg/kg FAM-labeled LNA oligonucleotide for three consecutive days, and spleens were dissected the day after last dose. (B) Quantitative RT-PCR analysis of miR-155 expression in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean +/- SD (n = 5). The LNA-antimiR compound effectively antagonizes miR-155 expression in LPS-treated mice compared to saline treated controls (*** indicates P < 0.001). (C) Western blot analysis of the c/ebp Beta LAP and LIP isoforms in splenocytes of mice treated with saline (n = 3), LNA-antimiR (n = 5) or LNA control (n = 5) by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 24 h after intraperitoneal injection of 0.5 mg/kg LPS. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Systemically delivered LNA-antimiR compound derepresses the LIP isoform of c/ebp Beta compared to both saline- and LNA control-treated mice (**P < 0.01). Values represent mean +/- SD.
###end p 34
###begin p 35
###xml 70 71 70 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 382 383 382 383 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 686 687 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 833 834 831 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 846 847 844 845 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 954 955 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 975 976 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 998 999 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1389 1390 1387 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 225 229 <span type="species:ncbi:10090">Mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1381 1385 <span type="species:ncbi:10090">mice</span>
miR-155 regulates c/ebp Beta in the splenocytes of LPS-treated mice. (A) Fluorescence-microscopy analysis of LNA oligonucleotide uptake in mouse splenocytes sorted in either B-cell (CD19) or monocytic (CD11b) cell fractions. Mice were dosed intravenously with 25 mg/kg FAM-labeled LNA oligonucleotide for three consecutive days, and spleens were dissected the day after last dose. (B) Quantitative RT-PCR analysis of miR-155 expression in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean +/- SD (n = 5). The LNA-antimiR compound effectively antagonizes miR-155 expression in LPS-treated mice compared to saline treated controls (*** indicates P < 0.001). (C) Western blot analysis of the c/ebp Beta LAP and LIP isoforms in splenocytes of mice treated with saline (n = 3), LNA-antimiR (n = 5) or LNA control (n = 5) by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 24 h after intraperitoneal injection of 0.5 mg/kg LPS. (Right) Quantification of the LIP and LAP protein bands shown on the western blot. Systemically delivered LNA-antimiR compound derepresses the LIP isoform of c/ebp Beta compared to both saline- and LNA control-treated mice (**P < 0.01). Values represent mean +/- SD.
###end p 35
###begin title 36
miR-155 mediates regulation of G-CSF
###end title 36
###begin p 37
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 789 790 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 803 804 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 838 839 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 931 939 931 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 945 954 945 954 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1056 1057 1056 1057 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1298 1299 1293 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1310 1311 1305 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1321 1322 1316 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1333 1334 1328 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1377 1378 1372 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1386 1387 1381 1382 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1727 1728 1720 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1738 1739 1731 1732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1781 1782 1774 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1790 1791 1783 1784 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2112 2113 2103 2104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2124 2125 2115 2116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2135 2136 2126 2127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2148 2149 2139 2140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2193 2194 2184 2185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 954 2200 954 2191 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="38">Antagonism of miR-155 leads to down-regulation of the granulocyte colony-stimulating factor (G-CSF). (<bold>A</bold>) Quantitative RT-PCR analysis of G-CSF expression normalized to &#946;2-microglobulin in Raw264.7 cells transfected with either LNA control (5 nM) or LNA-antimiR (5 nM) and stimulated with 100 ng/ml LPS for 6 h. Values represent mean &#177; SD (<italic>n</italic> = 5). The <italic>P</italic>-values (*<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01) are shown for two-sided Student's <italic>t</italic>-test. (<bold>B</bold>) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH after LPS-stimulation of THP-1 cells. THP-1 cells were cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) before LPS stimulation for 6 h. Values represent mean &#177; SD from one experiment performed in triplicate. The <italic>P</italic>-value (**<italic>P</italic> &lt; 0.01) is shown for two-sided Student's <italic>t</italic>-test. (<bold>C</bold>) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean &#177; SD (<italic>n</italic> = 5). The <italic>P</italic>-values (*<italic>P</italic> &lt; 0.05; ***<italic>P</italic> &lt; 0.001) are shown for two-sided Student's <italic>t</italic>-test.</p>
###xml 954 2200 954 2191 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="38">Antagonism of miR-155 leads to down-regulation of the granulocyte colony-stimulating factor (G-CSF). (<bold>A</bold>) Quantitative RT-PCR analysis of G-CSF expression normalized to &#946;2-microglobulin in Raw264.7 cells transfected with either LNA control (5 nM) or LNA-antimiR (5 nM) and stimulated with 100 ng/ml LPS for 6 h. Values represent mean &#177; SD (<italic>n</italic> = 5). The <italic>P</italic>-values (*<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01) are shown for two-sided Student's <italic>t</italic>-test. (<bold>B</bold>) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH after LPS-stimulation of THP-1 cells. THP-1 cells were cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) before LPS stimulation for 6 h. Values represent mean &#177; SD from one experiment performed in triplicate. The <italic>P</italic>-value (**<italic>P</italic> &lt; 0.01) is shown for two-sided Student's <italic>t</italic>-test. (<bold>C</bold>) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean &#177; SD (<italic>n</italic> = 5). The <italic>P</italic>-values (*<italic>P</italic> &lt; 0.05; ***<italic>P</italic> &lt; 0.001) are shown for two-sided Student's <italic>t</italic>-test.</p></caption>
###xml 2200 2200 2191 2191 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp577f5"/>
###xml 945 2200 945 2191 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="38">Antagonism of miR-155 leads to down-regulation of the granulocyte colony-stimulating factor (G-CSF). (<bold>A</bold>) Quantitative RT-PCR analysis of G-CSF expression normalized to &#946;2-microglobulin in Raw264.7 cells transfected with either LNA control (5 nM) or LNA-antimiR (5 nM) and stimulated with 100 ng/ml LPS for 6 h. Values represent mean &#177; SD (<italic>n</italic> = 5). The <italic>P</italic>-values (*<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01) are shown for two-sided Student's <italic>t</italic>-test. (<bold>B</bold>) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH after LPS-stimulation of THP-1 cells. THP-1 cells were cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) before LPS stimulation for 6 h. Values represent mean &#177; SD from one experiment performed in triplicate. The <italic>P</italic>-value (**<italic>P</italic> &lt; 0.01) is shown for two-sided Student's <italic>t</italic>-test. (<bold>C</bold>) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean &#177; SD (<italic>n</italic> = 5). The <italic>P</italic>-values (*<italic>P</italic> &lt; 0.05; ***<italic>P</italic> &lt; 0.001) are shown for two-sided Student's <italic>t</italic>-test.</p></caption><graphic xlink:href="gkp577f5"/></fig>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 350 355 <span type="species:ncbi:10090">mouse</span>
###xml 1880 1884 <span type="species:ncbi:10090">mice</span>
Recent studies using knockout mice have implicated miR-155 in the regulation of cytokines and chemokines in T and B cells (6,7). Thus, to identify immune response genes whose expression could be modulated by miR-155 in activated macrophages, we carried out expression profiling of RNA samples extracted from LPS-stimulated mouse Raw264.7 cells using mouse immune real-time RT-PCR arrays (). To establish a link between miR-155 and the expression of immune response genes, the LPS-stimulated Raw264.7 cells were transfected with either LNA-antimiR-155 or LNA control. Interestingly, among the immune response genes induced by LPS treatment, expression of the Csf3 gene encoding G-CSF was significantly down-regulated in LNA-antimiR-treated cells compared to the untreated and LNA controls (P = 0.014 and P = 0.008, respectively, Student's t-test, two-sided), implying that the regulation of G-CSF expression is mediated by miR-155 (Figure 5A, ). Figure 5.Antagonism of miR-155 leads to down-regulation of the granulocyte colony-stimulating factor (G-CSF). (A) Quantitative RT-PCR analysis of G-CSF expression normalized to beta2-microglobulin in Raw264.7 cells transfected with either LNA control (5 nM) or LNA-antimiR (5 nM) and stimulated with 100 ng/ml LPS for 6 h. Values represent mean +/- SD (n = 5). The P-values (*P < 0.05; **P < 0.01) are shown for two-sided Student's t-test. (B) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH after LPS-stimulation of THP-1 cells. THP-1 cells were cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) before LPS stimulation for 6 h. Values represent mean +/- SD from one experiment performed in triplicate. The P-value (**P < 0.01) is shown for two-sided Student's t-test. (C) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean +/- SD (n = 5). The P-values (*P < 0.05; ***P < 0.001) are shown for two-sided Student's t-test.
###end p 37
###begin p 38
###xml 102 103 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 344 345 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 356 357 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 367 368 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 379 380 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 423 424 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 432 433 427 428 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 773 774 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 784 785 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 827 828 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 836 837 829 830 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1158 1159 1149 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1170 1171 1161 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1181 1182 1172 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1194 1195 1185 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1239 1240 1230 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
Antagonism of miR-155 leads to down-regulation of the granulocyte colony-stimulating factor (G-CSF). (A) Quantitative RT-PCR analysis of G-CSF expression normalized to beta2-microglobulin in Raw264.7 cells transfected with either LNA control (5 nM) or LNA-antimiR (5 nM) and stimulated with 100 ng/ml LPS for 6 h. Values represent mean +/- SD (n = 5). The P-values (*P < 0.05; **P < 0.01) are shown for two-sided Student's t-test. (B) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH after LPS-stimulation of THP-1 cells. THP-1 cells were cotransfected with 5 nM pre-miR-155 in combination with either LNA control (5 nM) or LNA-antimiR (5 nM) before LPS stimulation for 6 h. Values represent mean +/- SD from one experiment performed in triplicate. The P-value (**P < 0.01) is shown for two-sided Student's t-test. (C) Quantitative RT-PCR analysis of G-CSF expression normalized to GAPDH in splenocytes of mice treated with LNA-antimiR or LNA control by three intravenous injections of 25 mg/kg over three consecutive days. Spleen samples were dissected 2 h after intraperitoneal injection of 0.5 mg/kg LPS. Values represent mean +/- SD (n = 5). The P-values (*P < 0.05; ***P < 0.001) are shown for two-sided Student's t-test.
###end p 38
###begin p 39
###xml 241 242 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 356 364 356 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 560 561 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 575 576 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 680 688 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 806 813 806 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
###xml 418 423 <span type="species:ncbi:9606">human</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 737 742 <span type="species:ncbi:10090">mouse</span>
To validate this conclusion we assessed the effect of miR-155 on G-CSF expression in human monocytic THP-1 cells. Transient transfection of pre-miR-155 into LPS-stimulated THP-1 cells resulted in significant up-regulation of the G-CSF mRNA (P < 0.01, Student's t-test, two-sided), that reverted to control levels upon antagonism of miR-155 by LNA-antimiR (Figure 5B). Consistent with our data on mouse macrophages and human monocytes, we observed that the G-CSF mRNA was significantly down-regulated in the splenocytes of miR-155 antagonized LPS-treated mice (P = 0.0007 and P = 0.02, Student's t-test, two-sided) compared to saline and LNA-control-treated animals, respectively (Figure 5C). The miR-155-mediated effect on G-CSF mRNA in mouse splenocytes was robust as it was observed in three independent in vivo experiments (data not shown). Considered together, our data suggest that miR-155 mediates regulation of G-CSF expression during acute inflammatory response.
###end p 39
###begin title 40
DISCUSSION
###end title 40
###begin p 41
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 691 700 691 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 977 985 977 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 987 988 987 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 989 991 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1067 1075 1067 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1406 1413 1406 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 745 751 <span type="species:ncbi:10090">murine</span>
###xml 1228 1232 <span type="species:ncbi:10090">mice</span>
###xml 1309 1314 <span type="species:ncbi:10090">mouse</span>
Inflammatory responses are initiated by monocytes that upon recognition of pathogens differentiate into macrophages, which then become activated to produce cytokines and chemokines. These inflammatory mediators help recruit effector cells to the site of infection and induce endothelial cell activation to increase vascular permeability (22). Several transcription factors are important for differentiation and activation of myeloid lineages, including the CCAAT/enhancer binding protein Beta (c/ebp Beta), which has been implicated in the regulation of proinflammatory cytokines during macrophage activation and the acute phase response (15,16). In this study, we show that c/ebp Beta is a bona fide target of miR-155 and that LPS treatment of murine macrophages strongly induces miR-155 expression, leading to translational repression of c/ebp Beta. Our observations are in good agreement with recent reports, showing that ectopically expressed miR-155 can target c/ebp Beta in vitro (9,24). Moreover we report here that functional inhibition of endogenous miR-155 in vitro leads to derepression of c/ebp Beta. Notably, we show for the first time that silencing of miR-155 by intravenously injected LNA-antimiR in LPS-treated mice results in marked derepression of the LAP and LIP isoforms of c/ebp Beta in mouse splenocytes, indicating that miR-155 acts as an important negative regulator of c/ebp Beta in vivo during acute inflammatory response.
###end p 41
###begin p 42
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 143 150 143 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1009 1011 1009 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 733 741 <span type="species:ncbi:9606">patients</span>
###xml 1248 1256 <span type="species:ncbi:9606">patients</span>
A new discovery of this study is the finding that antagonism of miR-155 by LNA-antimiR leads to down-regulation of the G-CSF mRNA in vitro and in vivo. G-CSF is a master regulator of granulopoiesis produced by activated macrophages during acute inflammatory responses (27). Several studies have demonstrated that G-CSF is involved in inflammation and that it aggravates inflammatory diseases (28). G-CSF appears to play a central role in arthritis, where administration of G-CSF to mice has been shown to enhance collagen-induced arthritis (29), while blocking of G-CSF, on the other hand, markedly reduced disease manifestation in mice (30). Furthermore, G-CSF-deficient mice are protected from acute and chronic arthritis (30). In patients with active rheumatoid arthritis, G-CSF is elevated in the serum and synovial fluid and correlates with disease severity (31). Hence, G-CSF is considered as a potential therapeutic target for intervention of inflammatory joint diseases, such as rheumatoid arthritis (28). However, therapies that antagonize G-CSF may lead to neutropenia. Thus, partial antagonism of endogenous G-CSF, as described in this study for LNA-antimiR-mediated G-CSF down-regulation, might provide a positive outcome for arthritis patients without increased risk of severe neutropenia. Indeed, our findings warrant further investigations of the potential anti-inflammatory effect of miR-155 antagonism in relevant animal models of inflammatory disease, such as collagen-induced arthritis.
###end p 42
###begin p 43
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 672 679 660 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 952 954 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 256 261 <span type="species:ncbi:10090">mouse</span>
Previous studies have reported on impaired induction of G-CSF in LPS-stimulated macrophages derived from mice expressing only the dominant-negative LIP form of c/ebp Beta (33). Interestingly, we find that overexpression of the LIP isoform of c/ebp Beta in mouse macrophages results in down-regulation of the G-CSF transcript (). Thus, it is possible that c/ebp Beta, which is modulated by miR-155, acts in part by fine-tuning G-CSF expression levels, consistent with a c/ebp Beta binding motif in the promoter of G-CSF (15,32). However, since a single vertebrate miRNA may target up to approximately100-200 mRNAs, it is highly likely that functional antagonism of miR-155 in vivo results in more complex downstream effects that are associated with miR-155-mediated gene regulatory networks. Indeed, miR-155 was recently shown to regulate the PI3K-AKT signaling pathway during LPS stimulation of macrophages by targeting the inositol phosphatase SHIP1 (34). Nevertheless, given the importance of c/ebp Beta during macrophage activation and the role of G-CSF in stimulating granulopoiesis in the bone marrow, our data emphasize the potential of antagonizing miR-155 for modulating activation of macrophages and the number of circulating granulocytic cells with possible implications for treatment of inflammatory diseases.
###end p 43
###begin title 44
SUPPLEMENTARY DATA
###end title 44
###begin p 45
 are available at NAR Online.
###end p 45
###begin title 46
[Supplementary Data]
###end title 46
###begin title 47
FUNDING
###end title 47
###begin p 48
The Danish National Advanced Technology Foundation, Danish Medical Research Council and the Lundbeck Foundation (to S.K.); Wilhelm Johannsen Centre for Functional Genome Research is established by the Danish National Research Foundation. Funding for open access charge: Santaris Pharma, Horsholm, Denmark.
###end p 48
###begin p 49
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. J.W., J.S., A.P., S.O., J.E., M.H., E.M.S., J.B.H. and S.K. are employed at Santaris Pharma. Santaris Pharma is a biopharmaceutical company engaged in the development of RNA based medicine.
###end p 49
###begin title 50
ACKNOWLEDGEMENTS
###end title 50
###begin p 51
The authors wish to thank Anja Konge, Charlotte Overup, Diana Kluver, Jane Hinrichsen, Janni Juul Jorgensen, Lisbeth Bang, Otto Olsen and Rikke Solberg for excellent technical assistance.
###end p 51
###begin p 52
 The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
###end p 52
###begin title 53
REFERENCES
###end title 53
###begin article-title 54
###xml 44 54 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
microRNAs: small molecules with big roles - C. elegans to human cancer
###end article-title 54
###begin article-title 55
MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications
###end article-title 55
###begin article-title 56
MicroRNAs in normal and malignant hematopoiesis
###end article-title 56
###begin article-title 57
microRNAs and the immune response
###end article-title 57
###begin article-title 58
MicroRNAs: novel regulators during the immune response
###end article-title 58
###begin article-title 59
Requirement of bic/microRNA-155 for normal immune function
###end article-title 59
###begin article-title 60
Regulation of the germinal center response by microRNA-155
###end article-title 60
###begin article-title 61
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
###end article-title 61
###begin article-title 62
MicroRNA-155 is induced during the macrophage inflammatory response
###end article-title 62
###begin article-title 63
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock
###end article-title 63
###begin article-title 64
microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells
###end article-title 64
###begin article-title 65
MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation
###end article-title 65
###begin article-title 66
MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase
###end article-title 66
###begin article-title 67
C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages
###end article-title 67
###begin article-title 68
Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6
###end article-title 68
###begin article-title 69
A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells
###end article-title 69
###begin article-title 70
Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs
###end article-title 70
###begin article-title 71
Colony-stimulating factors in inflammation and autoimmunity
###end article-title 71
###begin article-title 72
Regulation of desmocollin gene expression in the epidermis: CCAAT/enhancer-binding proteins modulate early and late events in keratinocyte differentiation
###end article-title 72
###begin article-title 73
###xml 39 44 <span type="species:ncbi:9606">human</span>
LNA-mediated microRNA silencing in non-human primates
###end article-title 73
###begin article-title 74
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver
###end article-title 74
###begin article-title 75
Expression profiling of lipopolysaccharide target genes in RAW264.7 cells by oligonucleotide microarray analyses
###end article-title 75
###begin article-title 76
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder
###end article-title 76
###begin article-title 77
###xml 19 37 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 66 84 <span type="species:ncbi:10376">Epstein-Barr virus</span>
MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways
###end article-title 77
###begin article-title 78
Differential activation of a C/EBP beta isoform by a novel redox switch may confer the lipopolysaccharide-inducible expression of interleukin-6 gene
###end article-title 78
###begin article-title 79
Transcriptional control of B-cell development
###end article-title 79
###begin article-title 80
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay
###end article-title 80
###begin article-title 81
Granulocyte colony-stimulating factor and neutrophils-forgotten mediators of inflammatory disease
###end article-title 81
###begin article-title 82
The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF
###end article-title 82
###begin article-title 83
Critical role for granulocyte colony-stimulating factor in inflammatory arthritis
###end article-title 83
###begin article-title 84
###xml 94 102 <span type="species:ncbi:9606">patients</span>
High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis
###end article-title 84
###begin article-title 85
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
###end article-title 85
###begin article-title 86
The C/EBP beta isoform 34-kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing
###end article-title 86
###begin article-title 87
Inositol phosphatase SHIP1 is a primary target of miR-155
###end article-title 87

